No photo of Roumen Deltchev Balabanov

View Scopus Profile

Roumen Deltchev Balabanov

  • 1935 Citations
1994 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Training Experience

1996Fellowship, Wayne State University
1999Internship, Wayne State University
2002Residency, University of Chicago Hospitals
2004Fellowship, University of Chicago Hospitals

Education/Academic qualification

MD, Medical Academy, Sofia, Bulgaria

… → 1991

Fingerprint Dive into the research topics where Roumen Deltchev Balabanov is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Regulation of Neuromyelitis Optica via Tolerance Induced by PLG Nanoparticles Encapsulating Aquaporin 4 Epitopes

Balabanov, R. D. & Miller, S. D.

National Institute of Allergy and Infectious Diseases

1/24/20 → 12/31/21

Project: Research project

    • Prot #101MS329: A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching Fro

    Balabanov, R. D.

    Quintiles, Inc., Biogen MA Inc.

    6/14/19 → 6/14/22

    Project: Research project

    Prot #EFC15824: A Phase 3, randomized, double-blind, global, placebo-controlled study to assess the efficacy and safety of alemtuzumab in participants with primary progressive multiple sclerosis (RUBY)

    Balabanov, R. D.

    Sanofi US Services Inc.

    4/2/19 → 4/2/20

    Project: Research project

    Identifying Immune Cell Surface Markers in Multiple Sclerosis and Other Autoimmune Diseases of the Nervous System

    Balabanov, R. D.

    NextCure, Inc.

    3/22/19 → 3/22/22

    Project: Research project

    Prot# 101MS407: A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patient”

    Balabanov, R. D.

    Quintiles, Inc., Biogen MA Inc.

    10/3/17 → 10/3/20

    Project: Research project

    Research Output

    Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica

    Burt, R. K., Balabanov, R., Han, X., Burns, C., Gastala, J., Jovanovic, B., Helenowski, I., Jitprapaikulsan, J., Fryer, J. P. & Pittock, S. J., Oct 29 2019, In : Neurology. 93, 18, p. E1732-E1741

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial

    Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., Fagius, J., Rose, J., Nelson, F., Barreira, A. A., Carlson, K., Han, X., Moraes, D., Morgan, A., Quigley, K., Yaung, K., Buckley, R., Alldredge, C., Clendenan, A., Calvario, M. A. & 3 others, Henry, J., Jovanovic, B. & Helenowski, I. B., Jan 15 2019, In : JAMA - Journal of the American Medical Association. 321, 2, p. 165-174 10 p.

    Research output: Contribution to journal › Article

    • 36 Scopus citations

    Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: A prespecified 2-year interim analysis of STRIVE

    Perumal, J., Fox, R. J., Balabanov, R. D., Balcer, L. J., Galetta, S., Makh, S., Santra, S., Hotermans, C. & Lee, L., Jun 8 2019, In : BMC Neurology. 19, 1, 116.

    Research output: Contribution to journal › Article

    Open Access

    • Treatment of natalizumab-associated PML with filgrastim

    Stefoski, D., Balabanov, R., Waheed, R., Ko, M., Koralnik, I. J. & Sierra Morales, F., May 1 2019, In : Annals of clinical and translational neurology. 6, 5, p. 923-931 9 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    B7-H4 modulates regulatory CD4+T cell induction and function via ligation of a semaphorin 3a/Plexin A4/Neuropilin-1 Complex

    Podojil, J. R., Chiang, M. Y., Ifergan, I., Copeland, R., Liu, L. N., Maloveste, S., Langermann, S., Liebenson, D., Balabanov, R. D., Chi, H., Chen, L., Vignali, D. A. A. & Miller, S. D., Aug 1 2018, In : Journal of Immunology. 201, 3, p. 897-907 11 p.

    Research output: Contribution to journal › Article

    • 9 Scopus citations